Alexander Gilman
Examiner (ID: 6523, Phone: (571)272-2004 , Office: P/2831 )
Most Active Art Unit | 2833 |
Art Unit(s) | 2833, 2831 |
Total Applications | 3105 |
Issued Applications | 2518 |
Pending Applications | 101 |
Abandoned Applications | 486 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17564423
[patent_doc_number] => 20220128572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/567623
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/567623 | IMMUNOLOGICAL SIGNATURES AND PARAMETERS PREDICTING THERAPEUTIC RESPONSES TO ANTI-TNF THERAPY | Jan 2, 2022 | Pending |
Array
(
[id] => 17685865
[patent_doc_number] => 20220193157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/557939
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557939 | LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION | Dec 20, 2021 | Pending |
Array
(
[id] => 18449512
[patent_doc_number] => 20230190788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications
[patent_app_type] => utility
[patent_app_number] => 17/551882
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551882 | Method and process to make chitosan-doped strontium oxide nanocomposite for bactericidal applications | Dec 14, 2021 | Issued |
Array
(
[id] => 17685922
[patent_doc_number] => 20220193214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Triple Vaccine for Diseases Caused by Salmonella typhimurium, Riemerella anatipestifer and Escherichia coli
[patent_app_type] => utility
[patent_app_number] => 17/532217
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532217 | Triple vaccine for diseases caused by | Nov 21, 2021 | Issued |
Array
(
[id] => 17561752
[patent_doc_number] => 20220125901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/527488
[patent_app_country] => US
[patent_app_date] => 2021-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17527488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/527488 | TREATMENT OF CANCER USING RECALL ANTIGENS DELIVERED BY ATTENUATED BACTERIA | Nov 15, 2021 | Abandoned |
Array
(
[id] => 17482150
[patent_doc_number] => 20220089654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/472936
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472936 | Mutant transporters for bacterial uptake of terephthalic acid | Sep 12, 2021 | Issued |
Array
(
[id] => 17593594
[patent_doc_number] => 20220143167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/347435
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347435
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347435 | SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF | Jun 13, 2021 | Pending |
Array
(
[id] => 17760059
[patent_doc_number] => 20220233671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SUBUNIT VACCINE OF CONTAGIOUS CAPRINE PLEUROPNEUMONIA AND PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/335573
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335573 | Subunit vaccine of contagious caprine pleuropneumonia and preparation method and use thereof | May 31, 2021 | Issued |
Array
(
[id] => 17242014
[patent_doc_number] => 20210361757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/327513
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -93
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327513 | STREPTOCOCCAL VACCINE FORMULATIONS AND USES THEREOF | May 20, 2021 | Pending |
Array
(
[id] => 17828431
[patent_doc_number] => 20220265735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => CANINE MICROBE PREPARATIONS FOR INCREASING OXYTOCIN
[patent_app_type] => utility
[patent_app_number] => 17/242635
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22014
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242635 | CANINE MICROBE PREPARATIONS FOR INCREASING OXYTOCIN | Apr 27, 2021 | Abandoned |
Array
(
[id] => 17170437
[patent_doc_number] => 20210324107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS
[patent_app_type] => utility
[patent_app_number] => 17/233901
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233901 | USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS | Apr 18, 2021 | Pending |
Array
(
[id] => 17034238
[patent_doc_number] => 20210251196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => IMMUNE-ENHANCED AQUACULTURE
[patent_app_type] => utility
[patent_app_number] => 17/176513
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176513 | Immune-enhanced aquaculture | Feb 15, 2021 | Issued |
Array
(
[id] => 18271575
[patent_doc_number] => 20230092817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 17/797055
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/797055 | RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER | Feb 11, 2021 | Pending |
Array
(
[id] => 18700080
[patent_doc_number] => 11786566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/141104
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 30
[patent_no_of_words] => 5877
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/141104 | None | Jan 3, 2021 | Issued |
Array
(
[id] => 19076507
[patent_doc_number] => 11945857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity
[patent_app_type] => utility
[patent_app_number] => 17/126396
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 52
[patent_no_of_words] => 17970
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/126396 | Methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity | Dec 17, 2020 | Issued |
Array
(
[id] => 17609820
[patent_doc_number] => 20220152099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Method for the preparation of an anti-streptococcus serum for use in the treatment of Coronavirus-related diseases.
[patent_app_type] => utility
[patent_app_number] => 16/951906
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/951906 | Method for the preparation of an anti-streptococcus serum for use in the treatment of Coronavirus-related diseases. | Nov 17, 2020 | Abandoned |
Array
(
[id] => 17154872
[patent_doc_number] => 20210315923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => LIPIDATED PSA COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/088547
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/088547 | LIPIDATED PSA COMPOSITIONS AND METHODS | Nov 2, 2020 | Pending |
Array
(
[id] => 18314132
[patent_doc_number] => 11628192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 17/082668
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 3995
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082668 | None | Oct 27, 2020 | Issued |
Array
(
[id] => 16807865
[patent_doc_number] => 20210130418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => CLAUDIN-TARGETING AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/073817
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073817
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073817 | Claudin-targeting agents and uses thereof | Oct 18, 2020 | Issued |
Array
(
[id] => 16620009
[patent_doc_number] => 20210038662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/028768
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17028768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/028768 | Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof | Sep 21, 2020 | Issued |